Cargando…
Screening for colorectal cancer in patients with inflammatory bowel disease. Should we already perform chromoendoscopy in all our patients?
Patients with inflammatory bowel disease (commonly known as IBD) have a greater risk of colorectal cancer than the general population. Therefore, they are included in special programs for screening and follow-up. Chromoendoscopy, which has a high diagnostic yield in the detection of neoplasia, is ge...
Autores principales: | Huguet, Jose María, Suárez, Patrícia, Ferrer-Barceló, Luis, Iranzo, Isabel, Sempere, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247098/ https://www.ncbi.nlm.nih.gov/pubmed/30487942 http://dx.doi.org/10.4253/wjge.v10.i11.322 |
Ejemplares similares
-
Endoscopic evaluation of immunotherapy-induced gastrointestinal toxicity
por: Iranzo, Isabel, et al.
Publicado: (2018) -
Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question
por: Gabbiadini, Roberto, et al.
Publicado: (2022) -
Colorectal cancer screening and surveillance in patients with inflammatory bowel disease in 2021
por: Huguet, Jose Maria, et al.
Publicado: (2022) -
Endoscopic recommendations for colorectal cancer screening and surveillance in patients with inflammatory bowel disease: Review of general recommendations
por: Huguet, Jose María, et al.
Publicado: (2017) -
The use of chromoendoscopy for surveillance of inflammatory bowel disease
por: Lichtenstein, Gary R., et al.
Publicado: (2018)